CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 175 filers reported holding CARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,049 | -73.7% | 213,644 | -42.5% | 0.01% | -84.5% |
| Q4 2022 | $3,987 | -99.7% | 371,262 | +184.4% | 0.06% | +262.5% |
| Q3 2022 | $1,222,000 | +5.6% | 130,521 | +3.0% | 0.02% | +14.3% |
| Q2 2022 | $1,157,000 | +86.0% | 126,746 | +147.8% | 0.01% | +75.0% |
| Q1 2022 | $622,000 | +81.3% | 51,155 | +81.5% | 0.01% | +100.0% |
| Q4 2021 | $343,000 | +34.5% | 28,190 | +57.7% | 0.00% | +33.3% |
| Q2 2021 | $255,000 | -77.4% | 17,877 | -65.6% | 0.00% | -81.2% |
| Q1 2021 | $1,128,000 | +305.8% | 51,963 | +137.5% | 0.02% | +166.7% |
| Q3 2020 | $278,000 | -1.4% | 21,880 | +32.8% | 0.01% | -14.3% |
| Q2 2020 | $282,000 | -15.6% | 16,482 | -20.6% | 0.01% | +16.7% |
| Q4 2019 | $334,000 | – | 20,755 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |